Compare Direxion Daily CSI China Internet Bull 2X Shares (CWEB) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily CSI China Internet Bull 2X Shares vs Quest Diagnostics Inc — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.91 (market cap $173.62M), while Quest Diagnostics Inc trades at $230.97 (market cap $25.48B). The key difference: Quest Diagnostics Inc is far larger — about 146.8× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Direxion Daily CSI China Internet Bull 2X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and Quest Diagnostics Inc for 56 Days on average.
| CWEB | DGX | |
|---|---|---|
Market Cap | $173.62M | $25.48B |
Volume | 551,726 | 941,866 |
Sector | Leveraged / Inverse | Health |
52-Week High | $54.91 | $247.45 |
52-Week Low | $17.39 | $173.49 |
Typical Hold Time | 24 Days | 56 Days |
Enterprise Value | — | $31.23B |
Dividend Yield | — | 1.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CWEB is trading at $17.57, down 2.5% today amid bearish technical signals. The stock shows weak momentum with 18 sell signals versus just 1 buy signal across technical indicators. Recent news highlights China's AI ambitions and potential for China growth stocks to surge, providing thematic tailwinds despite current technical weakness.
The outlook remains cautious with technical indicators pointing to continued pressure, though exposure to China's AI development offers long-term growth potential. Key risks include China market volatility and regulatory uncertainties, while the absence of fundamental data requires careful monitoring of upcoming financial disclosures.
Quest Diagnostics (DGX) trades at $230.81, up 1.68% with strong year-to-date performance driven by organic growth and advanced diagnostics adoption. The company has consistently beaten earnings expectations in recent quarters with Q2 2026 EPS of $3.12 exceeding estimates. Technical indicators show a bearish bias while fundamentals remain solid with 9.19% net margin and 14.35% ROE. Recent developments include a partnership with Apple Health app and positive clinical study results.
DGX presents a mixed outlook with strong fundamental performance offset by technical weakness and regulatory headwinds. The 38% upside to consensus price target of $250 offers potential, but Medicare reimbursement cuts and bearish technical signals warrant caution. Growth in consumer testing and strategic partnerships provide catalysts, though execution risks and debt levels require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Direxion Daily CSI China Internet Bull 2X Shares
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
